Strikingly, we find that either genetic or epigenetic perturbation of a single ERV-derived enhancer element leads to impaired cell growth by modulating expression of the APOC1 gene, suggesting that the activation of this particular ERV has a driving role in leukaemia cell phenotype. This evidence concerns the gene APOC1 and leukemia.